|4Apr 10, 6:42 PM ET

Bacchus Amir 4

4 · P3 Health Partners Inc. · Filed Apr 10, 2023

Insider Transaction Report

Form 4
Period: 2023-04-06
Bacchus Amir
DirectorChief Medical Officer
Transactions
  • Award

    Class A Common Stock

    2023-04-06+251,298251,298 total(indirect: By LLC)
  • Award

    Class A Common Stock

    2023-04-06+1,005,1931,005,193 total
  • Award

    Warrant

    2023-04-06+753,895753,895 total
    Exercise: $1.13Exp: 2028-04-05Class A Common Stock (753,895 underlying)
  • Award

    Warrant

    2023-04-06+188,474188,474 total(indirect: By LLC)
    Exercise: $1.13Exp: 2028-04-05Class A Common Stock (188,474 underlying)
Holdings
  • Class V Common Stock

    (indirect: By LLC)
    3,758,130
  • Class V Common Stock

    15,032,528
Footnotes (4)
  • [F1]The reported securities were issued in connection with the Issuer's sale of 1,005,193 Units purchased by the Reporting Person for $1.1938 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) 0.75 of a warrant to purchase one share of Class A Common Stock.
  • [F2]The reported securities were issued in connection with the Issuer's sale of 251,298 Units purchased by the Reporting Person for $1.1938 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) 0.75 of a warrant to purchase one share of Class A Common Stock.
  • [F3]These shares are held directly by Charlee Co LLC, an entity for which the Reporting Person serves as managing member.
  • [F4]Exercisable Immediately.

Documents

1 file
  • 4
    tm2312243-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT